Ge Healthcare Technologies Inc. GEHC
Revenue Intelligence Report • 16 quarters of SEC filing data • Updated 2026-03-15
Ge Healthcare Technologies Inc. (GEHC) has a forecasted full-year revenue of $882B, based on 16 quarters of SEC filing data.
Investment Thesis
Our ARDL model tracks Ge Healthcare Technologies Inc.'s revenue with exceptional precision (1.9% MAPE), indicating highly predictable cash flows. Every $1 of R&D investment is associated with $97609538083.25 of revenue, indicating efficient capital deployment in innovation. Each $1 of SG&A spending generates $12296169118.00 in revenue, reflecting strong commercial efficiency.
Next FY Revenue
$881.8B
+4175.6% YoY
R&D Multiplier
$97609538083.25 per $1
SG&A Multiplier
$12296169118.00 per $1
Model Accuracy
1.9% MAPE
Holdout validation: The model predicted $5.1B vs the actual $5.7B — an error of 9.9%.
Revenue Forecast
Quarterly Detail
| Quarter | Model Forecast | Actual | 95% Range | YoY Growth | Status |
|---|---|---|---|---|---|
| Q4 2025 | $5.1B | $5.7B | $4.9B – $5.4B | -3.5% | ✗ Outside range |
| Q2 2026 | $9.1B | $8.8B – $9.4B | +90.4% | ||
| Q3 2026 | $27B | $27B – $28B | +445.5% | ||
| Q4 2026 | $131B | $130B – $131B | +2445.7% | ||
| Q1 2027 | $714B | $714B – $715B | +12439.5% |
Seasonal Factors
Multiplicative seasonal adjustment:
These factors capture Ge Healthcare Technologies Inc.'s systematic quarterly revenue patterns relative to the trend model.
A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below.
Factors are computed as the median of (actual / fitted) across all available quarters.
| Fiscal Quarter | Seasonal Factor | vs Trend | Interpretation | Obs. |
|---|---|---|---|---|
| FQ1 (Sep–Nov) | 1.0209 | +2.1% | In line with trend | 3 |
| FQ2 (Dec–Feb) | 1.0128 | +1.3% | In line with trend | 4 |
| FQ3 (Mar–May) | 0.989 | -1.1% | In line with trend | 3 |
| FQ4 (Jun–Aug) | 0.9952 | -0.5% | In line with trend | 3 |
How Spending Drives Revenue
Reading this chart:
Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.
Want this analysis for your portfolio?
I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.
Get in Touch